1. Home
  2. SNY vs ADI Comparison

SNY vs ADI Comparison

Compare SNY & ADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • ADI
  • Stock Information
  • Founded
  • SNY 1994
  • ADI 1965
  • Country
  • SNY France
  • ADI United States
  • Employees
  • SNY N/A
  • ADI N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • ADI Semiconductors
  • Sector
  • SNY Health Care
  • ADI Technology
  • Exchange
  • SNY Nasdaq
  • ADI Nasdaq
  • Market Cap
  • SNY 116.1B
  • ADI 114.9B
  • IPO Year
  • SNY N/A
  • ADI 1972
  • Fundamental
  • Price
  • SNY $49.11
  • ADI $234.31
  • Analyst Decision
  • SNY Buy
  • ADI Buy
  • Analyst Count
  • SNY 4
  • ADI 22
  • Target Price
  • SNY $61.50
  • ADI $270.00
  • AVG Volume (30 Days)
  • SNY 3.9M
  • ADI 2.8M
  • Earning Date
  • SNY 10-24-2025
  • ADI 11-25-2025
  • Dividend Yield
  • SNY 3.25%
  • ADI 1.69%
  • EPS Growth
  • SNY 118.56
  • ADI 18.69
  • EPS
  • SNY 8.65
  • ADI 3.93
  • Revenue
  • SNY $53,714,621,258.00
  • ADI $10,386,795,000.00
  • Revenue This Year
  • SNY $1.53
  • ADI $17.26
  • Revenue Next Year
  • SNY $7.06
  • ADI $13.24
  • P/E Ratio
  • SNY $5.69
  • ADI $59.48
  • Revenue Growth
  • SNY 15.65
  • ADI 7.08
  • 52 Week Low
  • SNY $44.62
  • ADI $158.65
  • 52 Week High
  • SNY $60.12
  • ADI $258.13
  • Technical
  • Relative Strength Index (RSI)
  • SNY 54.77
  • ADI 34.31
  • Support Level
  • SNY $44.62
  • ADI $236.22
  • Resistance Level
  • SNY $51.05
  • ADI $246.20
  • Average True Range (ATR)
  • SNY 0.83
  • ADI 5.13
  • MACD
  • SNY 0.43
  • ADI -1.42
  • Stochastic Oscillator
  • SNY 68.73
  • ADI 0.35

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About ADI Analog Devices Inc.

Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.

Share on Social Networks: